A Broad(er) Conversation on Cell and Gene Therapies

Healthcare & Life Sciences Team Co-Leader Michael Werner will be a moderator for a panel at the 2024 FDLI Annual Conference in Washington, D.C. Mr. Werner's panel will examine the regulatory framework and global marketplace challenges related to cell and gene therapies in light of the U.S. Food and Drug Administration's (FDA) approval of the first cell-based gene therapy using CRISPR/Cas9.